Dexamethasone reduces cytokine mRNA levels and microglial activity in the brainstem of newborn rats
- Autores: Kalinina T.S.1,2, Bulygina V.V.1, Lanshakov D.А.1,2, Sukhareva E.V.1, Dygalo N.N.1,2
-
Afiliações:
- Federal research center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
- Novosibirsk State University
- Edição: Volume 41, Nº 3 (2024)
- Páginas: 240-246
- Seção: Experimental Articles
- URL: https://cardiosomatics.orscience.ru/1027-8133/article/view/653888
- DOI: https://doi.org/10.31857/S1027813324030039
- EDN: https://elibrary.ru/EQUVXL
- ID: 653888
Citar
Resumo
During the perinatal period of ontogenesis microglia, take part functions as a critical key-regulator of the angio-, neuro- and synaptogenesis processes. Under normal development, without inflammation induction, administration of the glucocorticoid hormone dexamethasone (0.2 mg/kg) caused a rapid decrease in the mRNA levels of both pro- and anti-inflammatory cytokines in the brainstem of neonatal rat pups. A decrease in the expression of the Il1b, Tnfa genes was observed within 1 hour, and Il10, Tgfb1 4 hours after the administration of the hormone to 3-day-old rat pups. Suppression of cytokine mRNA levels was accompanied by a decrease in the number of cells expressing the microglia marker protein IBA1 in the locus coeruleus region of the brain stem in 6 hours after glucocorticoid administration. The identified features of the dexamethasone action can weaken the participation of microglia in the processes of neuroplasticity in the developing brain, which may be one of the reasons for long-term changes in brain functioning.
Palavras-chave
Texto integral

Sobre autores
T. Kalinina
Federal research center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences; Novosibirsk State University
Autor responsável pela correspondência
Email: kalin@bionet.nsc.ru
Rússia, Novosibirsk; Novosibirsk
V. Bulygina
Federal research center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
Email: kalin@bionet.nsc.ru
Rússia, Novosibirsk
D. Lanshakov
Federal research center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences; Novosibirsk State University
Email: kalin@bionet.nsc.ru
Rússia, Novosibirsk; Novosibirsk
E. Sukhareva
Federal research center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences
Email: kalin@bionet.nsc.ru
Rússia, Novosibirsk
N. Dygalo
Federal research center Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences; Novosibirsk State University
Email: kalin@bionet.nsc.ru
Rússia, Novosibirsk; Novosibirsk
Bibliografia
- Sapolsky R.M., Romero L.M., Munck A.U. // Endocr. Rev. 2000. V. 21. P. 55–89.
- Sorrells S.F., Sapolsky R.M. // Brain Behav. Immun. 2007. V. 21. P. 259–272.
- Manuela Z., Julien P., Elodie B., Olivier B., Jérôme M. // Curr Neuropharmacol. 2021. V. 19. P. 2188–2204.
- Sarid E.B., Stoopler M.L., Morency A.M., Garfinkle J. // Pediatr. Res. 2022. V. 92. P. 1225–1239.
- Melan N., Pradat P., Godbert I., Pastor-Diez B., Basson E., Picaud J.C. // Eur. J. Pediatr. 2024. V. 183. P. 677–687.
- Zheng B., Zheng Y., Hu W., Chen Z. //Arch. Toxicol. 2024. V. 98. P. 1975–1990. doi: 10.1007/s00204-024-03733-2. Epub 2024 Apr 6. PMID: 38581585.
- Тишкина А.О., Степаничев М.Ю., Аниол В.А., Гуляева Н.В. // Успехи физиологических наук. 2014. Т. 45. №4. С. 3–18.
- Thion M.S., Ginhoux F., Garel S. // Science. 2018. V. 362. P. 185–189.
- Zengeler K.E., Lukens J.R. // Trends in Immunology. – 2024.
- Bilbo S.D., Smith S.H., Schwarz J.M. // J. Neuroimmune Pharmacol. 2012. V. 7. P. 24–41.
- Bilbo S.D., Block C.L., Bolton J.L., Hanamsagar R., Tran P.K. // Exp. Neurol. 2018. V. 299. P. 241–251.
- Walker D.J., Spencer K.A. // Gen. Comp. Endocrinol. 2018. V. 256. P. 80–88.
- Wang H., He Y., Sun Z., Ren S., Liu M., Wang G., Yang J. // J Neuroinflammation. 2022. V. 19. P. 132.
- Shishkina G.T., Kalinina T.S., Dygalo N.N. // Neuroscience. 2004. V. 129. P. 521–528.
- Kalinina T.S., Shishkina G.T., Dygalo N.N. // Neurochem. Res. 2012. V. 37. P. 811–818.
- Lanshakov D.A., Sukhareva E.V., Kalinina T.S., Dygalo N.N. // Neurobiol. Dis. 2016. V. 91. P. 1–9.
- Дыгало Н.Н., Науменко Е.В. //Докл. АН СССР. Сер. биол. 1983. Т. 271. № 4. С. 1003.
- Дыгало Н.Н., Юдин Н.С., Калинина Т.С., Науменко Е.В. // Онтогенетические и генетико-эволюционные аспекты нейроэндокринной регуляции стресса. Новосибирск: Наука. 1990. С. 136–148.
- Kreider M.L., Tate C.A., Cousins M.M., Oliver C.A., Seidler F.J., Slotkin T.A. // Neuropsychopharmacology. 2006. V. 31. P. 12–35.
- Slotkin T.A., Ko A., Seidler F.J. // Toxicology. 2018. V. 408. P. 11–21.
- Tsiarli M.A., Rudine A., Kendall N., Pratt M.O., Krall R., Thiels E., DeFranco D.B., Monaghan A.P. // Transl. Psychiatry. 2017. V. 7. e1153
- O’Donnell K.J., Meaney M.J. // Am. J. Psychiatry. 2017. V. 174. P. 319–328. doi: 10.1176/appi.ajp.2016.16020138. Epub 2016 Nov 14. PMID: 27838934.
- Scheinost D., Sinha R., Cross S.N., Kwon S.H., Sze G., Constable R.T., Ment L.R. // Pediatr. Res. 2017. V. 81. P. 214–226.
- Meyer J.S. // Physiol. Rev. 1985. V. 65. P. 946–1020.
- Park K.W., Lee H.G., Jin B.K., Lee Y.B. // Exp. Mol. Med. 2007. V. 39. P. 812–819.
- Bedolla A., Wegman E., Weed M., Paranjpe A., Alkhimovitch A., Ifergan I., McClain L., Luo Y. // bioRxiv [Preprint]. 2023. 2023.07.05.547814.
- Spittau B., Dokalis N., Prinz M. //Trends Immunol. 2020. V. 41. P. 836–848.
- Butovsky O., Jedrychowski M.P., Moore C.S., Cialic R., Lanser A.J., Gabriely G., Koeglsperger T., Dake B., Wu P.M., Doykan C.E., Fanek Z., Liu L., Chen Z., Rothstein J.D., Ransohoff R.M., Gygi S.P., Antel J.P., Weiner H.L. // Nat. Neurosci. 2014. V. 17. P. 131–143.
- Hui B., Yao X., Zhang L., Zhou Q. // Naunyn Schmiedebergs Arch. Pharmacol. 2020. V. 393. P. 1761–1768.
- Shishkina G.T., Kalinina T.S., Popova N.K., Dygalo N.N. // Behav. Neurosci. 2004. V. 118. P. 1285–1292.
- Dygalo N.N., Kalinina T.S., Shishkina G.T. // Ann. N. Y. Acad. Sci. 2008. V. 1148. P. 409–414.
- Sukhareva E.V., Kalinina T.S., Bulygina V.V., Dygalo N.N. // Russian Journal of Genetics: Applied Research. 2017. V. 7. P. 226–234.
- Kalinina T.S., Sukhareva E.V., Bulygina V.V., Lanshakov D.A., Egorova K.V., Dygalo N.N. // European Neuropsychopharmacology. 2019. V. 29. P. S166–S167.
- Liu Y.U., Ying Y., Li Y., Eyo U.B., Chen T., Zheng J., Umpierre A.D., Zhu J., Bosco D.B., Dong H., Wu L.J. // Nat. Neurosci. 2019. V. 22. P. 1771–1781.
- Mercan D., Heneka M.T. // Nat. Neurosci. 2019. V. 22. P. 1745–1746.
- Stowell R.D., Sipe G.O., Dawes R.P., Batchelor H.N., Lordy K.A., Whitelaw B.S., Stoessel M.B., Bidlack J.M., Brown E., Sur M., Majewska A.K. // Nat. Neurosci. 2019. V. 22. P. 1782–1792.
- Zou H.L., Li J., Zhou J.L., Yi X., Cao S. // Ibrain. 2021. V. 7. P. 309–317.
- Cronk J.C., Kipnis J. // F1000Prime Rep. 2013. V. 5. P. 53.
- Barry-Carroll L., Gomez-Nicola D. // Nat. Rev. Neurosci. 2024. V. 25. P. 414–427.
Arquivos suplementares
